Research Team for Social Participation and Community Health, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo, Japan
Institute for Global Health Policy Research, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
BMJ Open. 2022 Jun 16;12(6):e060829. doi: 10.1136/bmjopen-2022-060829.
While the development of vaccines against the Novel Coronavirus (COVID-19) brought hope of establishing herd immunity and ending the global pandemic, vaccine hesitancy can hinder the progress towards herd immunity. In this study, by analysing the data collected when citizens undergo public health restrictions due to the pandemic, we assess the determinants of vaccine hesitancy, reasons for hesitation and potential effectiveness of vaccine passports used to relax public health restrictions on mitigating vaccine hesitancy.
Cross-sectional study, longitudinal study and conjoint experimental design.
An online survey conducted in Japan in July 2021.
A demographically representative sample of 5000 Japanese adults aged 20-74.
COVID-19 vaccination intention RESULTS: We found that about 30% of respondents did not intend to get vaccinated or had not yet decided, with major reasons for vaccine hesitancy relating to concerns about the safety and side effects of the vaccine. In line with previous findings, younger age, lower socioeconomic status, and psychological and behavioural factors such as weaker COVID-19 fear were associated with vaccine hesitancy. Easing of public health restrictions such as travel, wearing face masks and dining out at night was associated with an increase in vaccine acceptance by 4%-10%. Moreover, we found that more than 90% of respondents who intended to get vaccinated actually received it while smaller proportions among those undecided and unwilling to get vaccinated did so.
With a major concern about vaccine safety and side effects, interventions to mitigate against these may help to reduce vaccine hesitancy. Moreover, when citizens are imposed with restrictions, vaccine passports that increase their freedom may be helpful to increase vaccination rates.
虽然针对新型冠状病毒(COVID-19)的疫苗的开发带来了建立群体免疫并结束全球大流行的希望,但疫苗犹豫可能会阻碍群体免疫的进展。在这项研究中,我们通过分析大流行期间公民接受公共卫生限制时收集的数据,评估了疫苗犹豫的决定因素、犹豫的原因以及用于放宽公共卫生限制以减轻疫苗犹豫的疫苗护照的潜在效果。
横断面研究、纵向研究和联合实验设计。
2021 年 7 月在日本进行的在线调查。
具有代表性的 5000 名 20-74 岁日本成年人的人口统计学样本。
COVID-19 疫苗接种意向。
我们发现,约 30%的受访者表示不打算接种疫苗或尚未决定,疫苗犹豫的主要原因与对疫苗的安全性和副作用的担忧有关。与之前的发现一致,年龄较小、社会经济地位较低、以及较弱的 COVID-19 恐惧等心理和行为因素与疫苗犹豫有关。放宽公共卫生限制,如旅行、戴口罩和夜间外出就餐,与疫苗接受度增加 4%-10%有关。此外,我们发现,超过 90%的打算接种疫苗的受访者实际上接种了疫苗,而在犹豫不决和不愿意接种疫苗的受访者中,这一比例较小。
由于对疫苗安全性和副作用的主要担忧,减轻这些担忧的干预措施可能有助于减少疫苗犹豫。此外,当公民受到限制时,增加他们自由的疫苗护照可能有助于提高疫苗接种率。